CADL - Candel Therapeutics, Inc.
IEX Last Trade
9.02
0.020 0.222%
Share volume: 23,471
Last Updated: Thu 26 Dec 2024 08:30:28 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$9.00
0.02
0.22%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-12 | 2022-08-05 | 2022-11-10 | 2023-03-30 | 2023-05-11 | 2023-08-10 | 2023-11-09 | |
| Total revenue | 31.000 K | 31.000 K | 31.000 K | 32.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 31.000 K | 31.000 K | 31.000 K | 32.000 K | 0.000 | 0.000 | 0.000 | |
| 0.00% | 0.00% | 3.23% | -100.00% | nan% | nan% | |||
| Operating expenses | 9.017 M | 8.784 M | 8.912 M | 8.134 M | 9.633 M | 9.579 M | 8.861 M | |
| Selling general and admin | 3.600 M | 3.762 M | 3.536 M | 3.162 M | 4.164 M | 3.645 M | 3.016 M | |
| Research and development | 5.417 M | 5.022 M | 5.376 M | 4.972 M | 5.469 M | 5.934 M | 5.845 M | |
| Total expenses | 9.017 M | 8.784 M | 8.912 M | 8.134 M | 9.633 M | 9.579 M | 8.861 M | |
| -2.58% | 1.46% | -8.73% | 18.43% | -0.56% | -7.50% | |||
| Operating income | -8.986 M | -8.753 M | -8.881 M | -8.102 M | -9.633 M | -9.579 M | -8.861 M | |
| Ebit | -8.986 M | -8.753 M | -8.881 M | -8.102 M | -9.633 M | -9.579 M | -8.861 M | |
| Pretax income | -874.000 K | -4.149 M | -8.688 M | -5.083 M | -8.795 M | -9.614 M | -8.435 M | |
| 374.71% | 109.40% | -41.49% | 73.03% | 9.31% | -12.26% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -874.000 K | -4.149 M | -8.688 M | -5.083 M | -8.795 M | -9.614 M | -8.435 M | |
| -374.71% | -109.40% | 41.49% | -73.03% | -9.31% | 12.26% | |||
| Net income | -874.000 K | -4.149 M | -8.688 M | -5.083 M | -8.795 M | -9.614 M | -8.435 M | |
| -374.71% | -109.40% | 41.49% | -73.03% | -9.31% | 12.26% |